David Wei

654 total citations · 1 hit paper
14 papers, 536 citations indexed

About

David Wei is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, David Wei has authored 14 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in David Wei's work include Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Fibroblast Growth Factor Research (2 papers). David Wei is often cited by papers focused on Chronic Myeloid Leukemia Treatments (7 papers), Chronic Lymphocytic Leukemia Research (4 papers) and Fibroblast Growth Factor Research (2 papers). David Wei collaborates with scholars based in United States, Canada and Ireland. David Wei's co-authors include Junlong Song, Huining Xiao, Yongcan Jin, Haiying Wei, Judith E. Karp, Ming Tan, Weidong Yang, Douglas D. Ross, Takeo Nakanishi and L. Austin Doyle and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cell Reports.

In The Last Decade

David Wei

11 papers receiving 527 citations

Hit Papers

Superhydrophobic modification of cellulose and cotton tex... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Superhydrophobic modification of cellulose and cotton textiles: Methodologies and applications
    2020 343 citations David Wei, Haiying Wei et al. Journal of Bioresources and Bioproducts profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Wei United States 6 154 146 146 88 66 14 536
Boyi Song United States 14 157 1.0× 110 0.8× 176 1.2× 171 1.9× 61 0.9× 25 853
Jingying Zhang China 14 140 0.9× 48 0.3× 158 1.1× 102 1.2× 90 1.4× 37 627
Qinghua Cao China 15 82 0.5× 65 0.4× 144 1.0× 232 2.6× 61 0.9× 31 600
Zhen Jia China 13 75 0.5× 84 0.6× 125 0.9× 257 2.9× 68 1.0× 31 629
Yuichiro Nishizawa Japan 20 68 0.4× 82 0.6× 123 0.8× 133 1.5× 77 1.2× 86 1.1k
Xiangfei Han China 13 325 2.1× 97 0.7× 260 1.8× 237 2.7× 69 1.0× 15 893
Xiaofang Zhang China 11 62 0.4× 34 0.2× 140 1.0× 124 1.4× 110 1.7× 52 582
John B. Garrison United States 18 130 0.8× 80 0.5× 186 1.3× 62 0.7× 138 2.1× 23 1.2k

Countries citing papers authored by David Wei

Since Specialization
Citations

This map shows the geographic impact of David Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Wei more than expected).

Fields of papers citing papers by David Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Wei. The network helps show where David Wei may publish in the future.

Co-authorship network of co-authors of David Wei

This figure shows the co-authorship network connecting the top 25 collaborators of David Wei. A scholar is included among the top collaborators of David Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Wei. David Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Atallah, Ehab, David Wei, Dominick Latrémouille-Viau, et al.. (2025). Treatment with asciminib after a prior tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia. Leukemia Research. 157. 108089–108089. 1 indexed citations
3.
Flynn, Kathryn E., et al.. (2025). Use of Patient-Reported Outcome Measures in Clinical Studies of Chronic Myeloid Leukemia: A Scoping Literature Review. Current Hematologic Malignancy Reports. 20(1). 15–15.
4.
Shafrin, Jason, et al.. (2024). Quantifying the financial impact of treatment intolerance in chronic myeloid leukemia on oncology clinical practices: A mixed methods study.. Journal of Clinical Oncology. 42(16_suppl). e18520–e18520. 1 indexed citations
5.
Takada, Yoko K., Xuesong Wu, David Wei, Samuel Hwang, & Yoshikazu Takada. (2024). FGF1 Suppresses Allosteric Activation of β3 Integrins by FGF2: A Potential Mechanism of Anti-Inflammatory and Anti-Thrombotic Action of FGF1. Biomolecules. 14(8). 888–888. 2 indexed citations
6.
7.
Atallah, Ehab, David Wei, Dominick Latrémouille-Viau, et al.. (2024). Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States. Clinical Lymphoma Myeloma & Leukemia. 25(3). 178–187.e2. 2 indexed citations
8.
9.
Wei, David, et al.. (2020). Superhydrophobic modification of cellulose and cotton textiles: Methodologies and applications. Journal of Bioresources and Bioproducts. 5(1). 1–15. 343 indexed citations breakdown →
10.
Prentice, Kacey J., Stacy G. Wendell, Ying Liu, et al.. (2017). CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis. EBioMedicine. 27. 200–213. 38 indexed citations
11.
Liu, Ying, Kacey J. Prentice, Cheng Hu, et al.. (2016). Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development. Cell Reports. 14(12). 2889–2900. 46 indexed citations
12.
Wei, David, Christian Pagnoux, & Clara C. Chan. (2016). Peripheral Ulcerative Keratitis Secondary to Chronic Hepatitis B Infection. Cornea. 36(4). 515–517. 8 indexed citations
13.
Nakanishi, Takeo, Judith E. Karp, Ming Tan, et al.. (2003). Quantitative analysis of breast cancer resistance protein and cellular resistance to flavopiridol in acute leukemia patients.. PubMed. 9(9). 3320–8. 62 indexed citations
14.
Sank, Anthony, David Wei, James Reid, et al.. (1994). Human Endothelial Cells Are Defective in Diabetic Vascular Disease. Journal of Surgical Research. 57(6). 647–653. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Boyi Song Breakdown of academic impact, for papers by Jingying Zhang Breakdown of academic impact, for papers by Qinghua Cao Breakdown of academic impact, for papers by Zhen Jia Breakdown of academic impact, for papers by Yuichiro Nishizawa Breakdown of academic impact, for papers by Xiangfei Han Breakdown of academic impact, for papers by Xiaofang Zhang Breakdown of academic impact, for papers by John B. Garrison
Rankless by CCL
2026